Literature DB >> 19773051

Vertebroplasty and kyphoplasty: reasons for concern?

Luca Denaro1, Umile Giuseppe Longo, Vincenzo Denaro.   

Abstract

Two different minimally invasive percutaneous vertebral augmentation methods for cement application into the vertebral body for the management of symptomatic compression fractures without neurologic impairment have been developed, namely, vertebroplasty and kyphoplasty. In vertebroplasty, polymethylmethacrylate cement is injected percutaneously into a collapsed vertebral body. Kyphoplasty involves placing an inflatable bone tamp percutaneously into a vertebral body. The inflation of the bone tamp with fluid allows restoration of vertebral height and correction of the kyphosis. After deflation, the cavity that has been produced is filled by injection of polymethylmethacrylate. This article provides an overview of the state of the art in vertebroplasty and kyphoplasty, discussing the indications, techniques, results, and pitfalls.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19773051     DOI: 10.1016/j.ocl.2009.05.004

Source DB:  PubMed          Journal:  Orthop Clin North Am        ISSN: 0030-5898            Impact factor:   2.472


  20 in total

1.  A novel injectable porous surface modified bioactive bone cement for vertebroplasty: an in vivo biomechanical and osteogenic study in a rabbit osteoporosis model.

Authors:  Jun Chen; Jin Yu; Qiang He; Xiong Zhao; Hongxun Sang; Wei Lei; Zixiang Wu; Jingyuan Chen
Journal:  Am J Transl Res       Date:  2015-03-15       Impact factor: 4.060

2.  A 3D finite element model of prophylactic vertebroplasty in the metastatic spine: Vertebral stability and stress distribution on adjacent vertebrae.

Authors:  Alessandra Berton; Giuseppe Salvatore; Hugo Giambini; Mauro Ciuffreda; Umile Giuseppe Longo; Vincenzo Denaro; Andrew Thoreson; Kai-Nan An
Journal:  J Spinal Cord Med       Date:  2018-02-15       Impact factor: 1.985

3.  Intraoperative navigation for minimally invasive resection of periarticular and pelvic tumors.

Authors:  Kevin Wu; Nicholas P Webber; Russell A Ward; Kevin B Jones; R Lor Randall
Journal:  Orthopedics       Date:  2011-05       Impact factor: 1.390

4.  The effectiveness and safety of vertebroplasty for osteoporotic vertebral compression fractures. A double blind, prospective, randomized, controlled study.

Authors:  Umile Giuseppe Longo; Mattia Loppini; Luca Denaro; Maria Luisa Brandi; Nicola Maffulli; Vincenzo Denaro
Journal:  Clin Cases Miner Bone Metab       Date:  2010-05

5.  Symptomatic disc herniation and serum lipid levels.

Authors:  Umile Giuseppe Longo; Luca Denaro; Filippo Spiezia; Francisco Forriol; Nicola Maffulli; Vincenzo Denaro
Journal:  Eur Spine J       Date:  2011-03-09       Impact factor: 3.134

6.  Scaffolds in tendon tissue engineering.

Authors:  Umile Giuseppe Longo; Alfredo Lamberti; Stefano Petrillo; Nicola Maffulli; Vincenzo Denaro
Journal:  Stem Cells Int       Date:  2011-12-11       Impact factor: 5.443

7.  Cement leakage causes potential thermal injury in vertebroplasty.

Authors:  Po-Liang Lai; Ching-Lung Tai; Lih-Huei Chen; Nai-Yuan Nien
Journal:  BMC Musculoskelet Disord       Date:  2011-05-26       Impact factor: 2.362

8.  Hypothermic manipulation of bone cement can extend the handling time during vertebroplasty.

Authors:  Po-Liang Lai; Ching-Lung Tai; I-Ming Chu; Tsai-Sheng Fu; Lih-Huei Chen; Wen-Jer Chen
Journal:  BMC Musculoskelet Disord       Date:  2012-10-16       Impact factor: 2.362

Review 9.  Tissue engineering for rotator cuff repair: an evidence-based systematic review.

Authors:  Nicola Maffulli; Umile Giuseppe Longo; Mattia Loppini; Alessandra Berton; Filippo Spiezia; Vincenzo Denaro
Journal:  Stem Cells Int       Date:  2011-11-10       Impact factor: 5.443

Review 10.  Growth factors and anticatabolic substances for prevention and management of intervertebral disc degeneration.

Authors:  Umile Giuseppe Longo; Stefano Petrillo; Edoardo Franceschetti; Nicola Maffulli; Vincenzo Denaro
Journal:  Stem Cells Int       Date:  2011-11-03       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.